Synthorx

Sanofi reveals setback for cancer drug acquired in Synthorx buyout
BioPharma Dive
Fri, 10/28/22 - 10:56 am
Sanofi
Synthorx
M&A
SAR444245
cancer
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
Mon, 04/12/21 - 11:34 pm
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg
Fierce Biotech
Fri, 04/9/21 - 10:37 am
Sanofi
solid tumors
Bristol Myers Squibb
Nektar Therapeutics
Synthorx
clinical trials
Sanofi C-suite explains Regeneron deal 'simplification,' ramping up its pipeline
Fierce Biotech
Fri, 02/7/20 - 10:19 am
Sanofi
M&A
Regeneron
Synthorx
Sanofi beat out 3 suitors and one last-minute bid in its pricey $2.5B Synthorx buyout
Fierce Pharma
Wed, 01/1/20 - 06:54 pm
Sanofi
Synthorx
M&A
immunotherapy
Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both
Motley Fool
Tue, 12/10/19 - 11:48 pm
Sanofi
immuno-oncology
M&A
Synthorx
Sanofi to acquire Synthorx for $2.5 billion
Marketwatch
Mon, 12/9/19 - 09:27 am
Sanofi
M&A
Synthorx
Top Scripps scientist and biotech co-founder makes an abrupt — and unexplained — exit
Endpoints
Sat, 08/10/19 - 01:57 pm
Scripps Research Institute
biotech
Synthorx
Preclinical biotech Synthorx wants a $100M IPO
Fierce Biotech
Wed, 11/14/18 - 11:51 am
IPOs
biotech
Synthorx
immuno-oncology
cytokines
La Jolla's Synthorx raises $63 million to make cancer drugs from bacterium with artificial DNA
San Diego Union Tribune, CA
Tue, 05/1/18 - 11:10 am
Synthorx
drug development
A biotech startup is expanding the DNA alphabet in hopes of making novel drugs
Stat
Wed, 07/20/16 - 10:07 am
biotech
drug discovery
DNA
R&D
Synthorx